The American Journal of Gastroenterology · 1999 · 79 citations · 22 references
Discontinuation of 6MP, while Crohn's disease is in remission, leads to higher relapse rates and continuation of 6MP reduces the likelihood of relapse. Therefore, we favor the indefinite use of 6MP once remission has been achieved.
22
Treatment of Crohn's Disease with 6-Mercaptopurine
Daniel H. Present, Burton I. Korelitz, Nathaniel Wisch et al. · New England Journal of Medicine · 1980 · 1K citations
A controlled double blind study of azathioprine in the management of Crohn's disease.
Sally Candy, John Wright, Michele Gerber et al. · Gut · 1995 · 570 citations · Full text